Hydromorphone hydrochloride preconditioning combined with postconditioning attenuates myocardial ischemia/reperfusion injury in rats by improving mitochondrial function and activating the PI3K /Akt signaling pathway
Chemical Biology & Drug Design · 2024-02 · 103 (2)
DOI: 10.1111/cbdd.14474 ↗At a glance
Journal article in Chemical Biology & Drug Design, published online on 2024-02-11. Written by Liuji Qiu and 6 co-authors. Institution: Department of Anesthesiology, Huizhou Central People's Hospital, Huizhou, Guangdong, China. Major MEDLINE topics: Myocardial Reperfusion Injury, Myocardial Infarction. Cited 9 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Thrombolytic therapy or percutaneous coronary intervention for myocardial infarction often cause myocardial ischemia/reperfusion injury (MIRI) and poor prognosis of patients. This study aimed to explore the protective effect and potential mechanism of hydromorphone hydrochloride (HH) on MIRI. Fifty Sprague–Dawley male rats were randomly divided into Sham group, I/R group, HH‐pre group, HH‐post group, and HH‐pre + post group. Except Sham group, MIRI models were established by ligating and relaxing the left anterior descending coronary artery, followed by tail vein injection of HH (0.3 μmol/L) 10 min before ligation (HH‐pre group), 10 min after reperfusion (HH‐post group), and twice at the above two time points (HH‐pre + post group). After intervention, the cardiac function of rats was evaluated by echocardiography, and the levels of myocardial injury markers, oxidative stress indicators, and mitochondrial function indicators were detected. Next, the myocardial infarction area was evaluated by 2,3,5‐triphenyltetrazolium chloride staining, mitochondrial biogenesis, and phosphoinositide 3 kinase (PI3K)/protein kinase B (Akt) signaling pathway by western blot. Compared with the I/R group, HH intervention improved cardiac function, decreased myocardial infarction area, reduced serum myocardial injury markers, alleviated oxidative stress, improved mitochondrial function, up‐regulated mitochondrial biogenesis, and activated PI3K/Akt signaling pathway. Moreover, the HH‐pre + post group was superior to the HH‐pre and HH‐post groups in the above aspects. Collectively, HH had protective effect on MIRI rats, and HH preconditioning combined with postconditioning showed optimal efficacy. Such efficacy may be achieved by promoting mitochondrial biogenesis to improve mitochondrial function and reduce oxidative stress, and activating the PI3K/Akt signaling pathway.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anesthesiology, Huizhou Central People's Hospital, Huizhou, Guangdong, China.
ORCID profiles: Liuji Qiu, Yan Yan, Guocheng Zhong, Zhiqi Hou, Yongcai Ye, Jiaying Lin, Dexing Luo
Cite
APA
Qiu, L., Yan, Y., Zhong, G., Hou, Z., Ye, Y., Lin, J., & Luo, D. (2024). Hydromorphone hydrochloride preconditioning combined with postconditioning attenuates myocardial ischemia/reperfusion injury in rats by improving mitochondrial function and activating the PI3K /Akt signaling pathway. Chemical Biology & Drug Design, 103(2). https://doi.org/10.1111/cbdd.14474
Vancouver
Qiu L, Yan Y, Zhong G, Hou Z, Ye Y, Lin J, et al. Hydromorphone hydrochloride preconditioning combined with postconditioning attenuates myocardial ischemia/reperfusion injury in rats by improving mitochondrial function and activating the PI3K /Akt signaling pathway. Chemical Biology & Drug Design. 2024;103(2). doi:10.1111/cbdd.14474
BibTeX
@article{Qiu2024,
author = {Qiu, Liuji and Yan, Yan and Zhong, Guocheng and Hou, Zhiqi and Ye, Yongcai and Lin, Jiaying and Luo, Dexing},
title = {Hydromorphone hydrochloride preconditioning combined with postconditioning attenuates myocardial ischemia/reperfusion injury in rats by improving mitochondrial function and activating the PI3K /Akt signaling pathway},
journal = {Chemical Biology & Drug Design},
year = {2024},
volume = {103},
number = {2},
doi = {10.1111/cbdd.14474}
}
EUVIMED